Abstract
MANY viruses have evolved mechanisms to avoid detection by the host immune system. Herpes simplex virus (HSV) expresses an immediate early protein, ICP47, which blocks presentation of viral peptides to MHC class I-restricted cells1. The properties of the newly synthesized class I molecules in HSV-infected cells resemble those of cell lines deficient in the transporter associated with antigen processing (TAP) in that class I molecules are retained in the endoplasmic reticulum1,2, and the heavy chain and β2-microglobulin subunits dissociate in detergent extracts but the complex can be stabilized by peptides1. We show here that ICP47 binds to TAP and prevents peptide translocation into the endoplasmic reticulum.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
York, I. A. et al. Cell 77, 525–535 (1994).
Hill, A. B., Barnett, B., McMichael, A. J. & McGeoch, D. J. Immun. 152, 2736 (1994).
Townsend, A. et al. Nature 340, 443–446 (1989).
Ljunggren, H. G. et al. Nature 346, 476–480 (1990).
Heemels, M.-T. & Ploegh, H. L. A. Rev. Biochem. 64, 463–491 (1995).
Yewdell, J. W. & Bennink, J. R. Adv. Immun. 52, 1–123 (1992).
Heemels, M.-T., Schumacher, T. N. M., Wonigeit, K. & Ploegh, H. L. Science 262, 2059–2063 (1993).
Schumacher, T. N. M., Kantesaria, D. V., Serreze, D. V., Roopenian, D. C. & Ploegh, H. L. Proc. natn. Acad. Sci. U.S.A. 91, 13004–13008 (1994).
Neefjes, J. J., Momburg, F. & Hämmerling, G. J. Science 261, 769–771 (1993).
Higgins, C. F. A. Rev. Cell Biol. 8, 67–113 (1992).
Shepherd, J. C. et al. Cell 74, 577–584 (1993).
van Endert, P. M. et al. Immunity 1, 491–500 (1994).
Androlewicz, M. J., Anderson, K. A. & Cresswell, P. Proc. natn. Acad. Sci. U.S.A. 90, 9130–9134 (1993).
de la Salle, H. et al. Science 265, 237–241 (1994).
Mavromara-Nazas, P., Ackermann, M. & Roizman, B. J. Viriol. 60, 807–812 (1986).
Roesle, J., Gromme, M., Momburg, F., Hämmerling, G. & Neefjes, J. J. exp. Med. 180, 1591–1597 (1994).
Heemels, M.-T. & Ploegh, H. L. Immunity 1, 775–784 (1994).
Ortmann, B., Androlewicz, M. J. & Cresswell, P. Nature 368, 864–867 (1994).
Suh, W.-K. et al. Science 264, 1322–1326 (1994).
Androlewicz, M. J., Ortmann, B., van Endert, P. M., Spies, T. & Cresswell, P. Proc. natn. Acad. Sci. U.S.A. 91, 12716–12720 (1994).
Beersma, M. F. C., Bijlmakers, M. J. E. & Ploegh, H. J. Immun. 151, 4455–4464 (1993).
Schägger, H. & vonJagow, G. Analyt. Biochem. 166, 368–379 (1987).
Cromme, F. V. et al. J. exp. Med. 170, 335–340 (1994).
Stam, N. J., Spits, H. & Ploegh, H. L. J. Immun. 137, 2299 (1986).
Neefjes, J. J., Breur-Vriewendorp, B. S., van Seventer, G. A., Ivanyi, P. & Ploegh, H. L. Hum. Immunol. 16, 169 (1986).
Colonna, M., Bresnahan, M., Bahram, S., Strominger, J. L. & Spies, T. Proc. natn. Acad. Sci. U.S.A. 89, 3932–3936 (1992).
Chakrabarti, S., Brechling, K. & Moss, B. Molec. cell. Biol. 5, 3403–3409 (1985).
Cox, J. H., Yewdell, J. W., Eisenlohr, L. C., Johnson, P. R. & Bennink, J. R. Science 247, 715–718 (1990).
Coupar, B. E., Andrew, M. E. & Boyle, D. B. Gene 68, 1–10 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hill, A., Jugovic, P., York, l. et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411–415 (1995). https://doi.org/10.1038/375411a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/375411a0
This article is cited by
-
Viral immune evasins impact antigen presentation by allele-specific trapping of MHC I at the peptide-loading complex
Scientific Reports (2022)
-
SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis
Nature Communications (2021)
-
Anti-viral Immunity in the Tumor Microenvironment: Implications for the Rational Design of Herpes Simplex Virus Type 1 Oncolytic Virotherapy
Current Clinical Microbiology Reports (2019)
-
Oncolytic viruses as engineering platforms for combination immunotherapy
Nature Reviews Cancer (2018)
-
Machinery that guides immunity
Nature (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.